Cargando…

Acute vasoreactivity test results in severe pulmonary hypertension patients with chronic obstructive pulmonary disease: our experience with 29 cases

AIM: The aim of the current study is to evaluate acute vasoreactivity test (AVT) results in severe pulmonary hypertension patients with chronic obstructive pulmonary disease and to compare the demographical, clinical, and laboratory variables in positive and negative cases. METHODS: This retrospecti...

Descripción completa

Detalles Bibliográficos
Autores principales:	Asker, Selvi, Asker, Muntecep
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2015
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4457217/ https://www.ncbi.nlm.nih.gov/pubmed/26064044 http://dx.doi.org/10.2147/COPD.S82856

Ejemplares similares

Serum levels of trace minerals and heavy metals in severe COPD patients with and without pulmonary hypertension
por: Asker, Selvi, et al.
Publicado: (2018)

An overlooked cause of resistant hypertension: upper airway resistance syndrome - preliminary results
por: Asker, Muntecep, et al.
Publicado: (2014)

A Behcet's Disease Patient with Right Ventricular Thrombus, Pulmonary Artery Aneurysms, and Deep Vein Thrombosis Complicating Recurrent Pulmonary Thromboembolism
por: Aşker, Selvi, et al.
Publicado: (2013)

Swyer–James–MacLeod syndrome with an anomalous origin of coronary artery: Case report
por: Aşker, Selvi, et al.
Publicado: (2013)

Multiparity and Spontaneous Coronary Artery Dissection in the Postpartum Period
por: Aşker, Müntecep, et al.
Publicado: (2012)

Clinical Study of Acute Vasoreactivity Testing in Patients with Chronic Thromboembolic Pulmonary Hypertension
por: Xu, Qi-Xia, et al.
Publicado: (2017)

Vasoreactive phenotype in children with pulmonary arterial hypertension and syncope
por: Linder, Alexandra N., et al.
Publicado: (2022)

Prognostic value of longitudinal vasoreactivity in pediatric pulmonary hypertension
por: Evers, Patrick D., et al.
Publicado: (2022)

Pulmonary Vascular Capacitance as a Predictor of Vasoreactivity in Idiopathic Pulmonary Arterial Hypertension Tested by Adenosine
por: Shafie, Davood, et al.
Publicado: (2015)

Acute vasoreactivity testing during right heart catheterization in chronic thromboembolic pulmonary hypertension: Results from the pulmonary vascular disease phenomics study
por: Frantz, Robert P., et al.
Publicado: (2023)

Pulmonary vasoreactivity in spontaneously hypertensive rats - Effects of endothelin-1 and leptin
por: Gomart, Samantha, et al.
Publicado: (2014)

Giant pulmonary artery aneurysm in a patient with vasoreactive pulmonary hypertension: a case report
por: Araújo, Inês, et al.
Publicado: (2011)

Platelet-to-Lymphocyte Ratio May Predict the Severity of Calcific Aortic Stenosis
por: Akdag, Serkan, et al.
Publicado: (2015)

Clinical Characteristics and Survival of Korean Idiopathic Pulmonary Arterial Hypertension Patients Based on Vasoreactivity
por: Ahn, Jee Hwan, et al.
Publicado: (2014)

Vasoreactive Pulmonary Arterial Hypertension Manifesting With Misleading Epileptic Seizure: Diagnostic and Treatment Pitfalls
por: Farhat, Nesrine, et al.
Publicado: (2019)

Acute vasoreactivity testing predicts outcome of idiopathic pulmonary arterial hypertension patients with a negative acute response
por: Sun, Yuanyuan, et al.
Publicado: (2020)

Cholesterol: A Novel Regulator of Vasoreactivity in Pulmonary Arteries
por: Grimmer, Benjamin, et al.
Publicado: (2020)

Vasoreactivity to inhaled nitric oxide with oxygen predicts long-term survival in pulmonary arterial hypertension
por: Malhotra, Rajeev, et al.
Publicado: (2011)

Primitive Neuroectodermal Tumor/Ewing Sarcoma Presenting with Pulmonary Nodular Lesions
por: Asker, Selvi, et al.
Publicado: (2015)

Comparison of Macitentan and Bosentan on Right Ventricular Remodeling in a Rat Model of Non-vasoreactive Pulmonary Hypertension
por: Iglarz, Marc, et al.
Publicado: (2015)

Assessments of the associations of thrombus localization with accompanying disorders, risk factors, D-dimer levels, and the red cell distribution width in pulmonary embolism
por: Sunnetcioglu, Aysel, et al.
Publicado: (2015)

Impact of hypertension severity on arterial stiffness, cerebral vasoreactivity, and cognitive performance
por: Muela, Henrique Cotchi Simbo, et al.
Publicado: (2017)

Successful management of pulmonary hemorrhage and aspergillosis in a patient with acute myeloid leukemia (AML-M3)
por: Gunbatar, Hulya, et al.
Publicado: (2015)

The relation of platelet–lymphocyte ratio and coronary collateral circulation in patients with non-ST segment elevation myocardial infarction
por: Akdag, Serkan, et al.
Publicado: (2016)

Outpatient Inhaled Nitric Oxide in a Patient with Vasoreactive Idiopathic Pulmonary Arterial Hypertension and COVID-19 Infection
por: Zamanian, Roham T., et al.
Publicado: (2020)

Cerebral vasoreactivity is not impaired in patients with severe sepsis
por: Szatmári, S, et al.
Publicado: (2011)

A Novel Echocardiographic Method for Assessing Arterial Stiffness in Obstructive Sleep Apnea Syndrome
por: Akdag, Serkan, et al.
Publicado: (2015)

Evaluation of Pulmonary Hypertension in Chronic Obstructive Pulmonary Disease
por: Aurangabadkar, Gaurang M, et al.
Publicado: (2022)

Altered vasoreactivity in neonatal rats with pulmonary hypertension associated with bronchopulmonary dysplasia: Implication of both eNOS phosphorylation and calcium signaling
por: Dumas de la Roque, Eric, et al.
Publicado: (2017)

Relationship of asymmetric dimethylarginine levels with disease severity and pulmonary hypertension in chronic obstructive pulmonary disease
por: Parmaksız, Elif Torun, et al.
Publicado: (2018)

Update on pulmonary hypertension complicating chronic obstructive pulmonary disease
por: Jyothula, Soma, et al.
Publicado: (2009)

Is There a Relationship Between Obstructive Sleep Apnea (OSA) and Hearing Loss?
por: Ekin, Selami, et al.
Publicado: (2016)

Impact of obstructive sleep apnea on pulmonary hypertension in patients with chronic obstructive pulmonary disease
por: Sun, Wan-Lu, et al.
Publicado: (2019)

Early-onset, Severe Chronic Obstructive Pulmonary Disease with Pulmonary Hypertension that was Likely Induced by Toluene Exposure
por: Kobayashi, Konomi, et al.
Publicado: (2017)

Pilot study of losartan for pulmonary hypertension in chronic obstructive pulmonary disease
por: Morrell, Nicholas W, et al.
Publicado: (2005)

Mechanisms of development of chronic obstructive pulmonary disease-associated pulmonary hypertension
por: Barberà, Joan Albert
Publicado: (2013)

Statins for the Treatment of Pulmonary Hypertension in Patients with Chronic Obstructive Pulmonary Disease
por: Chen, Chung-Yu, et al.
Publicado: (2021)

The role of vitamin D in chronic obstructive pulmonary disease with pulmonary hypertension
por: Li, Mengxi
Publicado: (2023)

Pulmonary function tests and impulse oscillometry in severe chronic obstructive pulmonary disease patients’ offspring
por: Amra, Babak, et al.
Publicado: (2015)

Persistence of pulmonary arterial hypertension after relief of left sided obstructive lesions in small infants: our experience
por: Munesh, T.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_9tolmu240p088023ca7unutjmd